Mesothelioma Treatment

Mesothelioma is a type of cancer that affects the outer membrane of internal organs. It is an aggressive cancer that spreads to vital organs of the body and may be caused by exposure to asbestos particles. People who inhale or ingest asbestos particles in the workplace where this hazardous material is used extensively, for instance in manufacturing units, may be in danger of contracting the disease. Asbestos particles may also cling to the clothes of workers proving harmful to their family as well. Too often, manufacturers failed to take the necessary safety precautions; despite being aware of the potential dangers asbestos exposure. In such cases, these victims may file a lawsuit against the manufacturer. Proving the case can be an uphill battle without the help of an experienced mesothelioma attorney.

Who are mesothelioma attorneys?

Mesothelioma is a rare form of cancer that affects the mesothelium, which is the inner lining that provides protection internal organs throughout the body; such as the abdomen, the heart and the lungs. Current research indicates that about 3000 people are annually diagnosed with this type of cancer which has no cure. This type of cancer does not usually develop overnight, but often has a latent, or dormant, period of decades before its symptoms begin to surface. People exposed to asbestos at higher levels are at the greatest risk of developing this disease.

Mesothelioma attorneys, Texas help victims fight lawsuits against manufacturers who often deliberately the possible effects of asbestos poisoning, despite being clearly aware of them. Mesothelioma attorneys, Texas are knowledgeable regarding the asbestos laws in their state as well as the statute of limitations pertaining to filing of asbestos-related lawsuits. Thus, mesothelioma attorneys, Texas can help victims achieve justice and fair compensation for themselves.

Another interesting study is called, “Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid
Clinical Lung Cancer” – Chest Surg Clin N Am. 1994 Feb;4(1):113-26 – Allen KB, Faber LP, Warren WH.  Here is an excerpt: “Abstract – Diffuse malignant pleural mesothelioma is an uncommon, uniformly fatal malignancy. Controversy continues to surround the optimal surgical procedure, both extrapleural pneumonectomy or pleurectomy, which should be utilized in conjunction with post-operative chemotherapy and/or radiotherapy. This retrospective study reviews a single institution’s experience with extrapleural pneumonectomy and pleurectomy in the multimodality treatment of diffuse malignant pleural mesothelioma.

Another interesting study is called, “Phase II trial of mitomycin in malignant mesothelioma.” By Bajorin, D, Kelsen, D, Mintzer, DM – CANCER TREAT.